WallStreetZenWallStreetZen

NASDAQ: DCGO
Docgo Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DCGO past earnings growth

How has DCGO's earnings growth performed historically?
Company
-79.41%
Industry
8.76%
Market
71.87%
DCGO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DCGO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

DCGO past revenue growth

How has DCGO's revenue growth performed historically?
Company
41.72%
Industry
8.53%
Market
17.2%
DCGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DCGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DCGO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DCGO earnings and revenue history

Current Revenue
$624.3M
Current Earnings
$6.9M
Current Profit Margin
1.1%

DCGO Return on Equity

Current Company
2.4%
Current Industry
-82.7%
Current Market
188%
DCGO's Return on Equity (2.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DCGO announces earnings.

DCGO Return on Assets

Current Company
1.6%
Current Industry
5.7%
DCGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DCGO Return on Capital Employed

Current Company
3.56%
Current Industry
11.9%
DCGO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DCGO vs Medical Care Facility Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DCGO$624.29M$27.85M$6.86M+89.61%-51.70%
MODV$2.76B-$23.04M-$204.46M+14.76%N/A
AIRS$195.92M$19.74M-$4.48M+47.64%N/A
BTMD$185.36M$15.85M$3.32M+13.94%-72.19%
AVAH$1.90B$44.35M-$134.52M+8.62%N/A
View Top Medical Care Facility Stocks

DCGO earnings dates

Next earnings date
May 8, 2024

Docgo Earnings & Revenue FAQ

What were DCGO's earnings last quarter?

On Invalid Date, Docgo (NASDAQ: DCGO) reported Q4 2023 earnings per share (EPS) of $0.08, up 0% year over year. Total Docgo earnings for the quarter were $7.57 million. In the same quarter last year, Docgo's earnings per share (EPS) was $0.08.

If you're new to stock investing, here's how to buy Docgo stock.

What was DCGO's earnings growth in the past year?

As of Q2 2024, Docgo's earnings has grown -79.41% year over year. This is 88.17 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 8.76%. Docgo's earnings in the past year totalled $6.86 million.

What is DCGO's earnings date?

Docgo's earnings date is Invalid Date. Add DCGO to your watchlist to be reminded of DCGO's next earnings announcement.

What was DCGO's revenue last quarter?

On Invalid Date, Docgo (NASDAQ: DCGO) reported Q4 2023 revenue of $199.25 million up 83.16% year over year. In the same quarter last year, Docgo's revenue was $108.78 million.

What was DCGO's revenue growth in the past year?

As of Q2 2024, Docgo's revenue has grown 41.72% year over year. This is 33.19 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 8.53%. Docgo's revenue in the past year totalled $624.29 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.